Rocket Pharmaceuticals, Inc. (RCKT)
1.98
-0.13
(-6.16%)
USD |
NASDAQ |
Nov 20, 15:09
Rocket Pharmaceuticals 30-Day Average Daily Volume : 1.904M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 1.904M |
| November 18, 2026 | 1.934M |
| November 17, 2026 | 1.944M |
| November 16, 2026 | 1.945M |
| November 13, 2026 | 1.936M |
| November 12, 2026 | 1.937M |
| November 11, 2026 | 1.975M |
| November 10, 2026 | 2.027M |
| November 09, 2026 | 2.024M |
| November 06, 2026 | 2.035M |
| November 05, 2026 | 2.075M |
| November 04, 2026 | 2.149M |
| November 03, 2026 | 2.186M |
| November 02, 2026 | 2.179M |
| October 30, 2026 | 2.164M |
| October 29, 2026 | 2.166M |
| October 28, 2026 | 2.167M |
| October 27, 2026 | 2.208M |
| October 26, 2026 | 2.261M |
| October 23, 2026 | 2.254M |
| October 22, 2026 | 2.256M |
| October 21, 2026 | 2.223M |
| October 20, 2026 | 2.185M |
| October 19, 2026 | 2.147M |
| October 16, 2026 | 2.115M |
| Date | Value |
|---|---|
| October 15, 2026 | 2.085M |
| October 14, 2026 | 2.061M |
| October 13, 2026 | 2.026M |
| October 12, 2026 | 1.950M |
| October 09, 2026 | 1.988M |
| October 08, 2026 | 1.918M |
| October 07, 2026 | 1.840M |
| October 06, 2026 | 1.819M |
| October 05, 2026 | 1.790M |
| October 02, 2026 | 1.766M |
| October 01, 2026 | 1.743M |
| September 30, 2026 | 1.721M |
| September 29, 2026 | 1.673M |
| September 28, 2026 | 1.685M |
| September 25, 2026 | 1.654M |
| September 24, 2026 | 1.604M |
| September 23, 2026 | 1.489M |
| September 22, 2026 | 1.453M |
| September 21, 2026 | 1.463M |
| September 18, 2026 | 1.461M |
| September 17, 2026 | 1.479M |
| September 16, 2026 | 1.483M |
| September 15, 2026 | 1.464M |
| September 14, 2026 | 1.448M |
| September 11, 2026 | 1.447M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Sarepta Therapeutics, Inc. | 2.419M |
| Intellia Therapeutics, Inc. | 5.158M |
| Beam Therapeutics, Inc. | 2.163M |
| Oncolytics Biotech, Inc. | 1.369M |
| Sangamo Therapeutics, Inc. | 1.137M |